Skip to main content
letter
. 2017 Jan 2;102(3):e112–e114. doi: 10.3324/haematol.2016.160408

Figure 1.

Figure 1.

Prior lines of therapy before the initiation of venetoclax. VRD: bortezomib, lenalidomide, dexamethasone; ASCT: autologous stem cell transplantation; Len Dex: lenalidomide, dexamethasone; PVD: pomalidomide, bortezomib, dexamethasone; Dara: daratumumab; BKD: bendamustine, carfilzomib, dexamethasone; CR: complete response, PR: partial response; SD: stable disease.